Hit enter to search or ESC to close
Neuron23
  • About
  • Our Science
  • Team
  • Partners
  • Join Us
  • News
  • Contact

News (title)

News (subtitle)
News

Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group

Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological and immunological diseases SOUTH SAN FRANCISCO, Calif., December 16, 2020 – Neuron23™…
fefifolios
fefifoliosDecember 15, 2020

About Us

Neuron23 is an early stage biotechnology company focused on developing personalized medicines for genetic disorders. Our mission is to create revolutionary treatments and future cures through advances in genetic research and our AI-enabled drug development platform.

Read More

Location

681 Gateway Blvd.
3rd Floor
South San Francisco, CA 94080

Contact Us

info.mail@neuron23.com

© 2021 Neuron23. All Rights Reserved

  • About
  • Our Science
  • Team
  • Partners
  • Join Us
  • News
  • Contact